Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06529731
What this trial is testing

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Sawa Ito, MD 57
Testing effectiveness (Phase 2)Study completedNCT02765802
What this trial is testing

Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection

Who this might be right for
Hepatitis D, Chronic
EIT Pharma, Inc. 33
Testing effectiveness (Phase 2)Looking for participantsNCT06536166
What this trial is testing

Ruxolitinib Treatment in Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis, Sporadic
Assistance Publique - Hôpitaux de Paris 80
Large-scale testing (Phase 3)Active Not RecruitingNCT02506153
What this trial is testing

Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+6 more
National Cancer Institute (NCI) 1,301
Early research (Phase 1)Study completedNCT00519792
What this trial is testing

Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment

Who this might be right for
Chronic Hepatitis C
Intarcia Therapeutics 60
Testing effectiveness (Phase 2)Study completedNCT00759200
What this trial is testing

Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Novartis 525
Large-scale testing (Phase 3)Ended earlyNCT00784836
What this trial is testing

Immunogenicity and Safety of Subcutaneously-administered Avonex (Interferon Beta-1a) in Multiple Sclerosis (MS) Patients

Who this might be right for
Multiple Sclerosis
Biogen 3
Testing effectiveness (Phase 2)Study completedNCT01058512
What this trial is testing

A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy

Who this might be right for
Hepatitis C
Cellectar Biosciences, Inc. 22
Not applicableStudy completedNCT05089565
What this trial is testing

Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis

Who this might be right for
SarcoidosisSARS-CoV2 InfectionVaccine Response Impaired
Northwestern University 101
Early research (Phase 1)Study completedNCT00908869
What this trial is testing

Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm

Who this might be right for
Advanced Neoplasm
Institut Paoli-Calmettes 30
Post-approval studies (Phase 4)UnknownNCT00597259
What this trial is testing

Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
National Taiwan University Hospital 294
Testing effectiveness (Phase 2)Ended earlyNCT00090870
What this trial is testing

PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Medical University of South Carolina 10
Post-approval studies (Phase 4)Ended earlyNCT01701856
What this trial is testing

Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Claudio Gobbi 5
Testing effectiveness (Phase 2)Study completedNCT01628094
What this trial is testing

ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 110
Large-scale testing (Phase 3)Study completedNCT00050531
What this trial is testing

High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)

Who this might be right for
Leukemia, Myeloid, Chronic
M.D. Anderson Cancer Center 94
Large-scale testing (Phase 3)Active Not RecruitingNCT00003641
What this trial is testing

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 1,150
Testing effectiveness (Phase 2)Study completedNCT00704405
What this trial is testing

Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 285
Large-scale testing (Phase 3)Study completedNCT01343888
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 656
Post-approval studies (Phase 4)Ended earlyNCT01443923
What this trial is testing

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Who this might be right for
HepatitisHIV/AIDS
National Institute of Allergy and Infectious Diseases (NIAID) 4
Post-approval studies (Phase 4)Study completedNCT00204555
What this trial is testing

Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma

Who this might be right for
Carcinoma, Basal Cell
University Hospital Tuebingen 100
Next Page